Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

hyperpolarized carbon C 13 pyruvate

A hyperpolarized pyruvate labeled with carbon C 13, with potential usage in the diagnostic imaging of cancer cells. Upon administration, carbon C 13 hyperpolarized pyruvate (13C-pyruvate) is taken up by cancer cells and is further metabolized to lactate and alanine for use in glycolysis, lipogenesis and protein synthesis, to support the enhanced metabolic needs of tumor cells. As tumor cells are rapidly proliferating, their uptake of pyruvate and its subsequent conversion to alanine and lactate are higher than non-proliferating cells. Upon nuclear magnetic resonance (NMR)-based imaging (MRI), both hyperpolarized 13C-pyruvate as well as its metabolites can be detected and visualized in cancer cells; this may aid in the diagnosis of cancer. Hyperpolarization of 13C-pyruvate, using dynamic nuclear polarization (DNP), enhances NMR signals.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:hyperpolarized 13C-pyruvate
hyperpolarized pyruvate (13C)
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search